MTIM
PODD icon

Marathon Trading Investment Management’s Insulet PODD Stock Holding History

Marathon Trading Investment Management’s Portfolio PODD Stock Details PODD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-5,665
Closed -$1.23M – 454
2023
Q4 		$1.23M Buy
+5,665
New +$972K 0.06% 144

Other funds holding PODD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marathon Trading Investment Management's PODD Position: Q1 2024 in Review

Marathon Trading Investment Management sold out of Insulet (PODD) in Q1 2024, closing a stake of 5,665 shares — an estimated $1.23M sold.

Marathon Trading Investment Management first reported a position in PODD in Q4 2023 and held it in 1 quarter. The position peaked at $1.23M in Q4 2023. 563 funds tracked by Wall St. Rank hold PODD as of Q1 2024.

  • Marathon Trading Investment Management reported no remaining Insulet position as of Q1 2024 after selling out during the quarter.
  • Marathon Trading Investment Management sold 5,665 Insulet shares in Q1 2024, an estimated $1.23M.
  • Marathon Trading Investment Management first reported a position in Insulet in Q4 2023 and held it in 1 quarter.
  • Marathon Trading Investment Management's Insulet position peaked at $1.23M in Q4 2023.
  • 563 funds tracked by Wall St. Rank held Insulet as of Q1 2024.

Based on Marathon Trading Investment Management's 13F filing for Q1 2024, filed 10 May 2024.